Navigation Links
Targeting astrocytes slows disease progression in ALS
Date:2/3/2008

In what the researchers say could be promising news in the quest to find a therapy to slow the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrigs disease, scientists at the University of California, San Diego (UCSD) School of Medicine have shown that targeting neuronal support cells called astrocytes sharply slows disease progression in mice.

The study, conducted in the laboratory of Don Cleveland, Ph.D., UCSD Professor of Medicine, Neurosciences and Cellular and Molecular Medicine and member of the Ludwig Institute for Cancer Research, will appear in the advance online publication on Nature Neuroscience's website on February 3rd.

Mutant genes that cause ALS are expressed widely, not just in the motor neurons, Cleveland explained. Targeting the partner cells like astrocytes, which live in a synergistic environment with the neuron cells, helps stop the cascade of damage. Therapeutically, this is the big news.

ALS is a progressive disease that attacks the motor neurons, long and complex nerve cells that reach from the brain to the spinal cord and from the spinal cord to the muscles throughout the body, which act to control voluntary movement. Degeneration of the motor neurons in ALS leads to progressive loss of muscle control, paralysis and untimely death. Estimated to affect some 30,000 Americans, most people are diagnosed with ALS between the ages of 45 and 65. Typically, ALS patients live only one to five years after initial diagnosis.

In findings published in Science in June 2006, Cleveland and his colleagues showed that in early stages of inherited ALS, small immune cells called microglia are damaged by mutations in the SOD1 protein, and that these immune cells then act to significantly accelerate the degeneration of the motor neurons. The new study demonstrates that much the same thing happens to astrocytes, support cells that are essential to neuronal function, and whose dysfunction is implicated
'/>"/>

Contact: Debra Kain
ddkain@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Targeting gut bugs could revolutionize future drugs, say researcher
2. New Research Shows Nutrition Programs Targeting Pregnancy and First 24 Months of Life Dramatically Improve Child Survival and Overall Health
3. APIC launches Targeting Zero initiative to eradicate infections deemed preventable by CMS
4. Tobacco marketers targeting teens near schools
5. Anticancer Drugs Targeting the ErbB (EGFr/HEr2) Pathway Alone Generated Global Sales of Nearly $5 Billion in the First Nine Months of 2007
6. Phase I pharmacokinetic study of ECO-4601, a novel bifunctional targeting agent
7. Isis Adds New Drug to Its Development Pipeline: ISIS 388626 Targeting SGLT2 for the Treatment of Type 2 Diabetes
8. Prime Access Creates Groundbreaking Ads Targeting Urban Teens for the White Houses National Youth Anti-Drug Media Campaign
9. Chronic infection persists by targeting stromal cell network in lymphoid organs
10. Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds
11. Sorafenib Slows Growth of Some Leukemias
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Anik Singal's Profit Academy - a ... has become the talk of the town throughout ... the course's general release has garnered the attention ... to review the program's content and publish an ... keys to success with Internet marketing is having ...
(Date:3/3/2015)... 2015 On February 21st, the rooftop ... EcoLuxe Lounge, a day-long event that features a gathering ... and services. Organized by Debbie Durkin and Durkin Entertainment, ... producer, the EcoLuxe Lounge saw many notable attendees. Among ... General Hospital, The Flash, Star Trek: Deep Space Nine ...
(Date:3/3/2015)... Findings could lead to better therapies ... have developed and characterized a molecule that interferes with ... self-destruct. This novel mechanism was found to be effective ... type of brain cancer – and could be applicable ... to be published in the April 2015 issue of ...
(Date:3/3/2015)... The Rheumatology Nurses Society (RNS) is ... and safe practice for patients with rheumatic diseases. , ... infusions are administered in an infusion center, provider’s office, ... nurse (RN), as defined in their State Nurse Practice ... receiving these medications during a first infusion, as well ...
(Date:3/3/2015)... The report “Alopecia – Pipeline Review, H1 ... Alopecia. Alopecia is the loss of hair. Alopecia areata ... alopecia. Causes for alopecia include aging, genetics, illness, chemotherapy, ... male pattern hair loss, female diffuse hair loss, hairs ... as focal or diffuse and by the presence or ...
Breaking Medicine News(10 mins):Health News:Anik Singal's Profit Academy - Review Of New IM Training Program Released 2Health News:Hollywood Star Chase Masterson and Choices Recovery Discuss Substance Abuse and Treatment at 2015 Oscars 2Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 2Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 3Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 4Health News:Administration of Biologic Infusions: A Position Statement of the Rheumatology Nurses Society 2Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 4
... Nov. 19 Mangos, a full-service advertising,agency, recently received ... a leading healthcare publication. The competition recognizes,exceptional creativity ... for the first time this year, and was the ... (Photo: http://www.newscom.com/cgi-bin/prnh/20081119/AQW573 ...
... 19 Governor Edward G. Rendell today revised his ... Health Care Cost Containment Council (PHC4). Under the revised order, ... or until the General Assembly reauthorizes the council, whichever occurs ... Governor acted similarly in 2003 when PHC4 was allowed to ...
... ALEXANDRIA, Va., Nov. 19 Recognizing November 20th as ... Cancer Society, the National Community Pharmacists Association House of ... to consider refraining from selling tobacco products in their ... pharmacies are renowned for helping their patients to maintain ...
... Consumer Watchdog said the health insurance industry,s support today ... it includes a requirement that every American buy insurance ... self-serving. The proposal amounts only to a customer delivery ... will not solve America,s health care problems and will ...
... Methodist University in Dallas are pioneering the use of ... Persian Gulf War veterans, aiming to pinpoint specific areas ... , Richard Gunst, Wayne Woodward and William Schucany, professors ... specialists at UT Southwestern Medical Center to compare brain ...
... And more is coming. At The University of Texas ... trainees are learning how to address the many issues ... received a 5-year, $1.3 million grant from the Agency ... young investigators how to conduct research in health information ...
Cached Medicine News:Health News:Mangos Wins Two Gold Awards 2Health News:Governor Rendell Revises Executive Order; Extends Operation of PA Health Care Cost Containment Council 2Health News:Governor Rendell Revises Executive Order; Extends Operation of PA Health Care Cost Containment Council 3Health News:NCPA Encourages Member Pharmacists to Consider Refraining From Selling Tobacco Products 2Health News:Consumer Watchdog Comments on Health Insurer's Self-Serving Support of 'Individual Mandate' 2Health News:Deep brain mapping to isolate evidence of Gulf War syndrome 2Health News:UT trainees tackle health information technology issues 2Health News:UT trainees tackle health information technology issues 3
(Date:3/3/2015)... , March 3, 2015   Surefire ... a prospective clinical trial comparing the Surefire Infusion System ... either primary or metastatic liver cancer, using the ... uptake of embolic agents, and with significantly decreased ... presented today at the Society of Interventional ...
(Date:3/3/2015)... 3, 2015  UnaliWear announces the market preview of ... seniors that guards against wandering and provides support for ... wearable – the Kanega watch ( http://www.UnaliWear.com ) – ... an easy speech interface rather than buttons, use cellular ... input. The watch goes wherever the ...
(Date:3/3/2015)... Ariz. , March 3, 2015  Michigan brothers ... heart condition called arrhythmogenic right ventricular dysplasia, or ARVD, a ... cause of sudden death among young athletes. In ... at a basketball game. They later tested Dominique and found ... to a February 19, 2015 story in The Ann ...
Breaking Medicine Technology:Clinical Trial Comparing the Surefire Infusion Device to an End Hole Catheter Finds Surefire Increases Tumor Uptake and Decreases Non-Target Embolization In Every Patient, Multiple Liver Cancer Types 2UnaliWear's Wearable For Seniors Extends Independence With Advanced Technology 2Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 2Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 3
Bayonet forceps....
Hardy bayonet forceps with stops. Insulated....
Cushing bayonet forceps. Insulated....
Insulated Bipolar Forceps...
Medicine Products: